Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

NeuroVive raises SEK70mm in PIPE

Executive Summary

NeuroVive Pharmaceutical AB (mitochondrial medicines for cardiovascular and neurological conditions) raised SEK70mm ($8.4mm) through the sale of 1.6mm new shares at SEK42.50 (an 18% discount) to US institutional investors. Chardan Capital Markets was the placement agent. Proceeds will help fund US clinical trials and European commercialization of its myocardial infarction drug CicloMulsion (IV cyclosporine) and preclinical studies for its organ protection candidate NVP019.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies